Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of HB-1 for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

NCT06483789 is registered in ClinicalTrials.gov with HB BioTech, LLC as lead sponsor.

NCT NCT06483789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06483789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of HB-1 for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
HB BioTech, LLC
Phase
Phase 2
Overall status
Terminated
Start date
October 29, 2024
Completion date
September 9, 2026
Enrollment
170 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

mental illness, panic disorder